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1 Executive summary
1.1 Summary of Key Points
  − Between 2% and 3% of both the nursing and pharmacist workforce are qualified to prescribe medicines 
independently
  − 93% of nurse prescribers and 80% of pharmacist prescribers had used their independent prescribing 
qualification.  86% of the nurses and 71% of the pharmacists were currently prescribing1
  − Nurses and pharmacists are prescribing predominantly in primary care, with substantial numbers also in 
secondary care settings
  − Study results indicate that overall, nurse and pharmacist prescribing is currently safe and clinically 
appropriate
  − The study findings indicate that current educational programmes of preparation for nurse and pharmacist 
prescribing are operating largely satisfactorily, and provide fit-for-purpose preparation
  − Evidence suggests that non-medical prescribing has been largely driven by individual practitioners to date, 
and has been used to increase the quality of existing services, as opposed to enabling service re-design
  − Only about half of Trusts reported a strategy or written plan for the development of non-medical 
prescribing
  − Key clinical governance and risk management strategies for non-medical prescribing are in place within the 
majority of Trusts
  − Acceptability of independent prescribing to patients is high, as evidenced by the majority of patients 
reporting that they were very satisfied with their visit to their nurse or pharmacist prescriber
  − When comparing care provided by their nurse or pharmacist independent prescriber to being treated by 
their GP, most patients in this study did not report a strong preference for either their non-medical or 
medical prescriber
  − Results indicate that non-medical prescribing was generally viewed positively by other health care 
professionals
  − Nurse and pharmacist independent prescribing in England is becoming a well–integrated and established 
means of managing a patient’s condition and giving him/her access to medicines
  − Key issues for further expansion of non-medical prescribing may include preparing nurses and pharmacists 
to prescribe across conditions for patients with co-morbidities
1  The survey was conducted in autumn 2008 when there were 358  pharmacist independent prescribers who had been qualified 
for longer than 6 months, and all were surveyed. NB In July 2010, there were more than 1,100 qualified pharmacist independent 
prescribers.